Cargando…
Safety of sildenafil in premature infants at risk of bronchopulmonary dysplasia: Rationale and methods of a phase II randomized trial
Bronchopulmonary dysplasia (BPD) is a disease of chronic respiratory insufficiency stemming from premature birth and iatrogenic lung injury leading to alveolar simplification, impaired alveolar-capillary development, interstitial fibrosis, and often pulmonary hypertension. BPD is the most common pul...
Autores principales: | Lang, Jason E., Hornik, Chi D., Martz, Karen, Jacangelo, Juliana, Anand, Ravinder, Greenberg, Rachel, Hornik, Christoph, Zimmerman, Kanecia, Smith, P. Brian, Benjamin, Daniel K., Laughon, Matthew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9636444/ https://www.ncbi.nlm.nih.gov/pubmed/36345347 http://dx.doi.org/10.1016/j.conctc.2022.101025 |
Ejemplares similares
-
Safety of sildenafil in premature infants with severe bronchopulmonary dysplasia (SILDI-SAFE): a multicenter, randomized, placebo-controlled, sequential dose-escalating, double-masked, safety study
por: Schneider, Simone, et al.
Publicado: (2020) -
In-hospital Outcomes of Premature Infants with Severe Bronchopulmonary Dysplasia
por: Jackson, Wesley, et al.
Publicado: (2017) -
Safety of sildenafil in extremely premature infants: a phase I trial
por: Jackson, Wesley, et al.
Publicado: (2021) -
Sildenafil and Retinopathy of Prematurity Risk in Very Low Birth Weight Infants
por: Samiee-Zafarghandy, Samira, et al.
Publicado: (2015) -
Physiologically-Based Pharmacokinetic Modeling Characterizes the CYP3A-Mediated Drug-Drug Interaction Between Fluconazole and Sildenafil in Infants
por: Salerno, Sara N., et al.
Publicado: (2020)